HCA:NYE-HCA Holdings Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 345.51

Change

-3.81 (-1.09)%

Market Cap

USD 89.71B

Volume

1.84M

Analyst Target

USD 147.05
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
THC Tenet Healthcare Corporation

-0.28 (-0.17%)

USD 15.44B
UHS Universal Health Services Inc

-1.74 (-0.86%)

USD 13.69B
DVA DaVita HealthCare Partners Inc

-2.92 (-1.86%)

USD 11.58B
EHC Encompass Health Corp

-1.48 (-1.44%)

USD 10.27B
CHE Chemed Corp

-2.63 (-0.47%)

USD 7.97B
CON Concentra Group Holdings Paren..

-0.23 (-1.12%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

+0.81 (+4.76%)

USD 2.59B
NHC National HealthCare Corporatio..

-2.68 (-2.06%)

USD 2.08B
BKD Brookdale Senior Living Inc

-0.11 (-2.02%)

USD 1.06B
AMN AMN Healthcare Services Inc

-0.73 (-2.97%)

USD 0.94B

ETFs Containing HCA

ZWHC:CA BMO Covered Call Health C.. 4.84 % 0.00 %

-0.14 (-0.21%)

N/A
YALL God Bless America ETF 4.46 % 0.00 %

-0.36 (-0.21%)

N/A
MHG:AU Magellan Global Equities 4.24 % 0.00 %

N/A

USD 0.11B
MGE:AU 4.11 % 0.00 %

N/A

N/A
HLTH:AU VanEck Global Healthcare .. 2.09 % 0.00 %

+0.05 (+-0.21%)

USD 0.06B
XLVE:CA Mulvihill U.S. Health Car.. 1.79 % 0.00 %

-0.03 (-0.21%)

N/A
ENGUS:PA BNP Paribas Easy ECPI Glo.. 1.18 % 0.00 %

-0.02 (-0.21%)

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

-0.96 (-0.21%)

N/A
NASH 0.00 % 0.49 %

N/A

N/A
PKW Invesco BuyBack Achievers.. 0.00 % 0.62 %

-1.12 (-0.21%)

USD 1.22B
PTH Invesco DWA Healthcare Mo.. 0.00 % 0.60 %

-1.41 (-0.21%)

USD 0.14B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

-0.12 (-0.21%)

CAD 0.09B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 27.65% 57% F 83% B
Dividend Return 0.73% 50% F 10% F
Total Return 28.38% 57% F 82% B
Trailing 12 Months  
Capital Gain 43.71% 57% F 86% B+
Dividend Return 1.07% 50% F 12% F
Total Return 44.78% 57% F 85% B
Trailing 5 Years  
Capital Gain 150.28% 94% A 91% A-
Dividend Return 7.03% 71% C- 19% F
Total Return 157.31% 94% A 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 32.07% 78% C+ 89% A-
Dividend Return 32.97% 78% C+ 88% B+
Total Return 0.90% 33% F 21% F
Risk Return Profile  
Volatility (Standard Deviation) 36.95% 57% F 27% F
Risk Adjusted Return 89.24% 96% N/A 94% A
Market Capitalization 89.71B 100% F 98% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.